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Objective: Asymptomatic pyuria (ASP) is associated with a higher risk of complicated urinary tract
infections among diabetic patients. We investigated the association between glycemic status and ASP in
an adult population undergoing a health checkup in Hualien, east-central Taiwan.
Materials and Methods: We reviewed the records of 9229 participants who had their ﬁrst health checkup
in this hospital between June 1, 2001 and September 1, 2006. All cases (n ¼ 979) had pyuria as deﬁned by
the presence of more than 10 leukocytes per high-power ﬁeld in urinalysis. Controls (n ¼ 8250) included
all other patients who had no pyuria. The glycemic status was classiﬁed as normal [fasting blood glucose
(FBG) <100 mg/dL and no diabetes history], prediabetic (FBG, 100e125 mg/dL and no diabetes history),
and diabetic (FBG >125 mg/dL or a history of diabetes). A case-control analysis was performed. Odds
ratios (ORs) were calculated by logistic regression.
Results: The prevalences of ASP for diabetic, prediabetic, and normal adults were 23.4%, 18.0%, and 13.4%
in women, and 5.6%, 4.2%, and 4.6% in men, respectively. Among women, the age-adjusted OR for ASP
was 1.34 (p < 0.01) for prediabetics and 1.77 (p < 0.01) for diabetics, relative to the controls (p for trend
<0.01). Among men, the corresponding OR was 0.91 (p ¼ 0.59) for prediabetics and 1.15 (p ¼ 0.44) for
diabetics. The effects of glycemic status on ASP signiﬁcantly differed among women versus those among
men (p for interaction <0.01). The associations remained unchanged after further adjustments for other
potential confounding factors.
Conclusion: An abnormal glycemic status has a signiﬁcant positive dose-response relation with the
presence of ASP; however, the association is only in women and not in men. Further research is required
to protect diabetic women from this complication.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Diabetic patients have an increased risk of symptomatic urinary
tract infections (UTIs) and UTI complications (e.g., bacteremia, renal
abscesses, and renal papillary necrosis), especially among wom-
en.1e4 It has been suggested that asymptomatic bacteriuria (ASB) is
a major risk factor of developing symptomatic UTIs and subsequent
renal dysfunction.5,6,7 Several reports have shown that people with
diabetes have a higher prevalence of ASB compared with those
without diabetes, especially among women.8e11 ASB has been
shown to be a predictor for hospitalization with a UTI in diabeticesearch and Department of
Road, Hualien 970, Taiwan.
.
ciation. Published by Elsevier Taiwadults.12 Some investigators have even suggested that ASB is
a complication of diabetes in women.13 However, data are con-
ﬂicting as to whether people with diabetes do have a higher
prevalence of ASB.14e16 Furthermore, most of the research has been
conducted among women in Western countries, and mostly in
clinic- or hospital-based populations. There is evidence suggesting
that the association between diabetes and ASB may differ among
different ethnic groups. For example, a study in an Asian population
failed to show a higher prevalence of ASB in diabetic women.16 In
addition, data are limited regarding the proposed association in
men.4 To our knowledge, there are no reports on whether ASB is
more prevalent among people with diabetes in Taiwan, either male
or female. To further investigate these issues, we conducted this
research in a population of Taiwanese people undergoing a health
checkup that included adult men and women to assess the rela-
tionship between diabetes and ASB. Urine culture and urinaryan LLC. Open access under CC BY-NC-ND license.
Table 1
Characteristics of cases (with UTI) and controls (non-UTI) among the health checkup
population in Hualien, 2001e2006
Variables Cases
(n ¼ 979)
Controls
(n ¼ 8250)
Age at exam date, mean (standard deviation) 62.2 (13.5)a 60.1 (12.9)
Body mass indexb, mean (standard deviation) 24.8 (3.9) 24.8 (3.7)
Sex (male), % 21.1a 50.5
Smoking (ever), % 12.6a 18.7
Alcohol consumption, % 18.0a 29.4
Betel nut consumption, % 10.4 11.5
Hypertensionc, % 29.3 30.0
Dyslipidemiad, % 33.5a 30.4
Hyperuricemia, % 18.4 18.0
Liver dysfunction, % 8.1 9.8
Renal insufﬁciency, % 7.0a 3.9
Glycemia status, %
Normal FS 54.6a 61.8
Prediabetes 22.3a 21.9
Diabetes 23.1a 16.3
a p < 0.05.
b weight (kg)/height (m)2.
c history of hypertension or BP >130/85 mmHg.
d history of dyslipidemia or serum triglycerides 150 mg/dL.
FS ¼ fasting sugar; UTI ¼ urinary tract infection.
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ASB.10,17 We used pyuria as a surrogate for bacteriuria in this study.
2. Materials and methods
2.1. Study group
The study group comprised participants who had a health
checkup sponsored by the National Health Insurance in our hospital
between June 1, 2001 and September 1, 2006. The NHI-sponsored
health checkup program is a nationwide project that offers a peri-
odic free comprehensive health exam to beneﬁciaries aged 40 years
and older. The free health checkup service is offered annually to
people aged 65 years and older, but every 3 years to those aged
40e64 years. Some participants had more than one health checkup
in this hospital during the study period, but we analyzed only data
from the ﬁrst health checkup.
2.2. Deﬁnition of pyuria and glycemic disorders
There were 9229 participants in the study. A case-control
analysis was conducted. Cases (n ¼ 979) were patients who had
pyuria, which was deﬁned as the presence of more than 10
leukocytes per high-power ﬁeld in the urinalysis. Controls
(n ¼ 8250) comprised the other patients who had no pyuria. As
a health checkup population, these patients were assumed to be
asymptomatic. Their glycemic status was classiﬁed as normal [with
a fasting blood glucose (FBG) of <100 mg/dL and no history of
diabetes], prediabetic (with a FBG of 100e125mg/dL and no history
of diabetes), or diabetic (with a FBG of>125mg/dL or with a history
of diabetes).
2.3. Data collection
After a fasting period of at least 8 hours, a complete blood count,
fasting blood sugar, renal function, liver function, uric acid, lipid
proﬁle, and sediment urinalysis were conducted in participants.
They then completed questionnaires regarding their medical
history (diabetes, hypertension, and hyperlipidemia), smoking,
alcohol consumption, betel nut chewing, demographic factors, and
family history of major cardiovascular diseases. A physician then
carried out a physical examination of the participants. Data on their
blood tests were automatically entered into an electronic database,
while data from the questionnaires were manually entered into the
same database. Participants were enrolled in this study if they had
complete data on their glycemic status (a history of diabetes and
FBG) and urinalysis. We used the database to explore the rela-
tionship between glycemic status and asymptomatic pyuria (ASP).
The potential confounding factors considered were age, sex, body
mass index (BMI), smoking, alcohol consumption, betel nut chew-
ing, a history of hypertension or hyperlipidemia, hyperuricemia
(serum uric acid >7.2 mg/dL), liver dysfunction (glutamate pyru-
vate transaminases >42 mg/dL), and nephropathy (serum creati-
nine >1.5 mg/dL). BMI and age were considered as continuous
variables, while all others were treated as categorical variables. This
study was approved by the institutional review committee of the
hospital.
2.4. Statistical analysis
Logistic regression was used to analyze the relation between
glycemic status and ASP while adjusting for other potential con-
founding factors, including age, sex, history of hypertension,
smoking, alcohol consumption and nephropathy. Other factors
were tested for their effects on the odds ratio (OR) estimate andwere not included in the model, since they did not change the OR
estimate for diabetes by 10% or more. We ﬁrst examined whether
the glycemic status of the cases and controls differed, as well as
other potential confounding factors. Because sex was found to have
different effects on the glycemiaeASP association, we then assessed
the glycemiaeASP association stratiﬁed by sex. The ORs were
calculated with 2005 Stata statistical software (Intercooled Stata
8.2; Stata Corporation, College Station, TX, USA).
3. Results
The prevalence of ASP was 10.6% [95% conﬁdence interval (CI):
9.9e11.2%] in this population, with 15.9% (95% CI: 14.9e16.9%) for
women and 4.7% (95% CI: 4.1e5.3%) formen. The prevalences of ASP
in adults with glycemic statuses classiﬁed as diabetic, prediabetic,
and normal were 23.4%, 18.0%, and 13.4% in women, and 5.6%, 4.2%,
and 4.6% in men, respectively. Of the 9229 participants, 1572 had
a diabetic, 2024 had a prediabetic, and 5633 had a normal glycemic
status.
Table 1 shows the characteristics of the cases and controls. The
two groups had no differences in terms of BMI, betel nut chewing,
hypertensive status, hyperuricemia, or liver dysfunction. The cases
were more likely to be older, female, dyslipidemic, and nephro-
pathic, but they were less likely to be smokers or drink alcohol. The
prevalence of prediabetes and/or diabetes tended to be higher in
the cases than in controls.
The effects of glycemic status on ASP appeared to differ among
women versus men (p for interaction <0.01). Table 2 shows the
relationship between glycemic status and ASP stratiﬁed by sex.
Among women, those with a prediabetic glycemic status had a 34%
higher estimated risk of ASP (age-adjusted OR: 1.34; 95% CI:
1.11e1.64; p < 0.01), and those with diabetes had a 77% higher
estimated risk of ASP compared with controls (age-adjusted OR:
1.77; 95% CI: 1.45e2.18; p < 0.01). A clear linear trend was present
for this association among women (p< 0.01). In contrast, there was
no association between glycemic status and ASP among men. The
age-adjusted OR was 0.91 (p ¼ 0.59) for those with a prediabetic
glycemic status and 1.15 (p ¼ 0.44) for those with diabetes
compared with controls. Further adjustments for nephropathy,
hypertension, smoking, and alcohol consumption did not signiﬁ-
cantly change the OR estimates.
Table 2
Odds ratios of ASP associated with glycemia status, stratiﬁed by sex
Variables Cases (%) Controls (%) Odds ratioa 95% CI p
Glycemia status
(females)
n ¼ 773 n ¼ 4088
Normal 54.0 66.0 Reference Reference d
Prediabetes 22.6 19.6 1.34 1.11 1.64 0.00
Diabetes 23.4 14.5 1.77 1.45 2.18 0.00
p for trend <0.01
Glycemia status
(males)
n ¼ 206 n ¼ 4162
Normal 56.8 57.7 Reference Reference d
Prediabetes 21.4 24.2 0.91 0.63 1.29 0.59
Diabetes 21.8 18.1 1.15 0.80 1.64 0.44
p for trend ¼ 0.40
a Adjusted for age: the association remained similar after further adjustment for
renal insufﬁciency, hypertension, smoking, and alcohol.
ASP ¼ asymptomatic pyuria; CI ¼ conﬁdence interval.
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The deﬁnition of ASB is not consistent among different
studies.10,17 Several studies used urine culture to deﬁne ASB, while
one study used ASP (pyuria) as an indication of ASB10. In the current
study, ASP was used as an indication of ASB. Regardless of which
criteria were used, misclassiﬁcation of ASB status is possible. Most
studies have shown prevalences of ASB that range from 6% to 10%
using urine culture.9,16,17 The prevalence of ASP in 10.6% in the
current population is comparable with that of previous studies. The
prevalence of ASP among diabetic women was 23.4% in our study,
which is also similar to two other studies. Nakano et al reported
a prevalence of ASP of 27.9% (pyuria was deﬁned as the presence
oﬂess than 10 leukocytes per high-power ﬁeld) among diabetic
women in Japan,10 and Geerlings et al13 documented 26.0% ASB
(bacteriuria by urine culture) among 378 diabetic women.
Our results suggest that glycemic disorders may increase the
risk of ASB in a dose-response manner (p< 0.01), but the effect was
limited to women, and was not detected in men (p < 0.01).
Although the data are not totally consistent, several reports on
Western populations have shown that diabetic women have
a higher prevalence of ASB compared with women without the
condition.8,9,13,18 The current study of a Taiwanese population
supports the concept that the prevalence of ASB is higher in dia-
betic women (23.4%) than that in women with a normal glycemic
index (13.4%), with an age-adjusted OR of 1.77 (p< 0.01). If diabetes
does predispose to ASB, we can speculate that prediabetes also
predisposes to ASB. Previous studies have rarely examined whether
being prediabetic also increases the risk of ASB. Our data are unique
in further showing that even a prediabetic status alone increases
the estimated risk of ASB by 34% inwomen (OR: 1.34, p< 0.01). This
doseeresponse relationship greatly augments the plausibility of an
association between glycemic disorders and ASB in women.
Furthermore, there are few data on whether the proposed associ-
ation is also true formen. Available data suggest that the prevalence
of ASB is not increased in diabetic men versus nondiabetic men.19,20
Our data are consistent with previous reports that diabetes does
not lead to a higher prevalence of ASB in men. We further showed
that a prediabetic status also does not increase the risk of ASB
in men.
Age is a well-established risk factor for ASB in diabetic women,
while other covariates, such as thedurationor control of diabetes, the
presence of complications of diabetes including nephropathy and
retinopathy, and sexual intercourse, have also been proposed.13,21
In our study, the glycemiaeASP association remained unchanged
after adjusting for age andnephropathy. Residual confounding is stillpossible since we have no data on other covariates. We believe that
the inﬂuence should be limited since age and nephropathy are
usually positively associated with the duration of diabetes. In addi-
tion, although the distributions of participants who smoked and/or
drank alcohol differed between the cases and controls, further
adjustment for those factors did not signiﬁcantly change the OR
estimates in this study.
This study has several strengths. First, there were a relatively
large number of cases with ASP, yielding a higher power compared
with other studies. Second, this was a population-based study
with participants recruited from a health checkup program, not
diseased populations, thus enhancing the external validity. Third,
in contrast to other studies, we explored the association between
diabetes and ASB, and that between prediabetes and ASB. The
linear trend we found between prediabetes and diabetes with ASB
in women strongly supports the theory that glycemic disorders
increase the risk of ASB, which in turn may increase the risk of
symptomatic UTIs. Fourth, our data showed that glycemic disor-
ders are associated with a higher risk of ASP in women, but not in
men. Fifth, in contrast to most other reports, this study provides
data from a non-Western population that support the proposed
association.
There are also some limitations to our study that deserve
discussion. First, we were unable to differentiate between the two
primary types of diabetes mellitus: insulin-dependent diabetes
mellitus (type I) and non-insulin-dependent diabetes mellitus
(type II). The metabolic proﬁles of the two types may differ, but
Geerlings et al showed that women with type I diabetes also have
a higher prevalence of ASB compared with normal controls.13 We
believe that this difference between types may have had little effect
on our results because themajority of diabetic patients in this study
were aged 40 years or older, and therefore most likely to be of type
II. Second, we used pyuria deﬁned by urinary leukocyte counts
instead of urine culture as a surrogate for bacteriuria. The use of this
deﬁnition might have led us to observe a less strong association
between ASP and diabetes. Third, we assumed that people in this
health checkup population were asymptomatic. If that assumption
was wrong, the bias might have resulted in a stronger association
between ASP and diabetes. Another limitation is that as this was
a retrospective study, we were unable to control for some other
potential confounding factors pertaining to UTIs, including the
presence of anomalies of the urinary tract and the consumption of
cranberries, which may have reduced the risk of UTI.
Some authors have proposed the following mechanisms to
explain why ASB may be more prevalent in people with diabetes,
although none have been conﬁrmed. First, the higher glucose
concentration in the urine of diabetic patients may serve as
a culture medium allowing bacteria to grow faster.22 Second, those
with diabetes may have an impaired host defense system. Diabetic
women have lower urinary interleukin-6 concentrations compared
with those in normal controls, and interleukin-6 may attenuate
host defense mechanisms against systemic and local infections23,24.
Tamm-Horsfall protein is a glycoprotein produced in the kidneys
and excreted in urine to prevent bacterial attachment to uroepi-
thelial cells by binding type I and S ﬁmbriae of Escherichia coli.25,26
Some investigators have proposed that in diabetics, Tamm-Horsfall
protein may have a different chemical structure that makes it easier
for E. coli to adhere to diabetic uroepithelial cells.27,28 Third, there
is evidence showing an increased adherence of E. coli to type I
ﬁmbriae of uroepithelial cells isolated from diabetic women
compared with those from control patients.29 It has been suggested
that diabetic cystopathy and peripheral neuropathy may contribute
to the higher risk of UTIs in diabetic patients, but researchers have
failed to ﬁnd a correlation between them.13,30 Infecting bacteria in
the urine of diabetic people have also not been found to be more
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sible pathogenesis as to why people with diabetes are predisposed
to ASB is available as described above, those explanations cannot
explain why the effects of glycemic disorders on ASB are only
evident in women and not in men.
The clinical implications of ASB can be signiﬁcant. Ribera et al6
demonstrated that ASB is a major risk factor for developing
symptomatic UTIs. They followed 289 women and 168 men over
a 12-month period. Among patients with ASB, 69.2% (67.6% of
women and 76.5% of men) developed symptomatic UTIs, while only
9.8% without ASB (14.9% of women and 2.6% of men) developed
symptomatic UTIs.6 Although some investigators disagree about
treating asymptomatic UTIs in people with diabetes,32 we believe
prospective randomized trials are necessary to determine whether
treating asymptomatic UTIs prevents symptomatic UTIs.
5. Conclusions
Our results suggest that patients with glycemic disorders have
a higher prevalence of ASB, but this is true only for women, not for
men. The reason why glycemic disorders are not associated with
a higher risk of ASB among men remains unclear. Further research
is required to determine how to protect womenwith diabetes from
this diabetic complication.
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